1 Product identity
Ingredient risk
Not yet assessed

BCAA

BrandPureAmino acid/Protein Capsule 5 ingredients DSLD #248623
Net contents: 365 Capsule(s)
Target: Adults and Children 4 years and above
DSLD entry: 2021-08-23
2 Ingredients (5)
IngredientGroupSafety
Branched-Chain Amino AcidsBlend
L-Isoleucine, MicronizedIsoleucine
L-Valine, MicronizedValine
Gelatin Capsulescapsule
Ingredient amounts require the full DSLD label. View full label at NIH DSLD →
3 Safety cross-reference
L-Leucine — Limited Evidence
⚠ May worsen pellagra
⚠ High doses may impair glucose metabolism
4 Label claims
• Nutrient
• All Other
• Structure/Function
5 Data source
DSLD ID248623
SourceOffice of Dietary Supplements, NIH
Market statusOn market
Entry date2021-08-23
6 More from Pure
View Pure Safety Scorecard → 21 products
B კომპლექსი პლუსი 60 კაფსულა ფიური - PureDHEA 25მგ 60 კაფსულა ფიური - PureEPA-DHA 90 კაფსულა ფიური - PureGABA 60 კაფსულა ფიური - PureNაცეტილ Lცისტეინ 600 30 კაფსულა ფიური - PurePMS ესენციალი 60 კაფსულა ფიური - Pure
7 Cite this page
Vancouver
Pkhakadze G. BCAA — product analysis [Internet]. Tbilisi: Public Health Institute of Georgia; 2026 [cited 2026 Aug 27]. Available from: https://supplement.ge/products/dsld-248623/
CC BY 4.0. Product data from NIH DSLD; safety analysis by SupplementIndex.
GP
Analyzed by SupplementIndex
PHIG · Editor-in-Chief: Prof. Giorgi Pkhakadze, MD, MPH, PhD
Product data sourced from the NIH Dietary Supplement Label Database (DSLD). Safety cross-referencing by SupplementIndex. This analysis is for informational purposes only. For corrections: info@accreditation.ge.
Publisher: PHIG
© 2026 supplement.ge · PHIG · Sheni Network